ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Effects of Interpersonal Psychotherapy on Depression During and After Pregnancy

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Effects of Interpersonal Psychotherapy on Depression During and After Pregnancy
Official Title  Infant Outcomes and Depression Treatment in Pregnancy
Brief Summary

This study will evaluate the impact of interpersonal psychotherapy on the course of depression during and after pregnancy, as well as its effect on infant birth outcomes.

Detailed Description

Depression is a serious illness that affects a person's body, mood, and thoughts. Researchers believe that it is one of the most common complications during and after pregnancy. The following symptoms may be signs of depression during pregnancy: 2 or more weeks of depressed mood; decreased interest or pleasure in activities; change in appetite or sleep patterns; fatigue or decreased energy; difficulty concentrating; excessive feelings of guilt or worthlessness; thoughts of suicide; and extreme restlessness or irritability. Depression is difficult to diagnose during pregnancy because its symptoms are sometimes confused with those of pregnancy. If left untreated, depression during pregnancy may affect not only the mother, but also the baby. Specifically, the hormone changes brought on by depression may contribute to premature and low-birth-weight infants. Interpersonal psychotherapy (IPT) is a short-term talking therapy that has been proven to be effective in treating depression. This study will evaluate the impact of interpersonal psychotherapy on the course of depression during and after pregnancy, as well as its effect on infant birth outcomes.

This study is associated with a larger parent study. Participants in this open-label study may be recruited directly for this study or through the parent study. All participants will receive 16 sessions of IPT. Sessions will last approximately 50 minutes and will focus on achieving depression symptom remission by improving interpersonal functioning. The majority of IPT sessions will be held prior to delivery; up to four sessions may be held postpartum. No medication will be provided in this study, but women who are currently taking selective serotonin uptake inhibitors (SSRIs) at the time of study entry may continue taking their medication. Participants whose symptoms do not improve with IPT will be referred to their non-study physician for further evaluation, and may begin taking SSRI medication upon physician recommendation. The effects of both IPT and medication therapy will be considered when assessing outcomes. Study visits will occur at 28, 32, and 36 weeks gestation, as well as Weeks 1, 2, and 6, and Month 6 postpartum. Measurements will include cortisol levels, which will be obtained using a saliva sample, as well as depression symptom severity, which will be assessed at each IPT session. Blood samples will be taken as part of the parent study.

Study Phase
Study Type  Interventional
Study Design  Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Primary Outcome Measure  Mothers' depression symptom severity, as determined by the 17-item Hamilton Rating Scale for Depression (HAM-D 17) [ Time Frame: Measured during pregnancy and the first 7 months after delivery ] [ Designated as safety issue: Yes ]
Infant birth outcomes [ Time Frame: Measured during the first 7 months after delivery ] [ Designated as safety issue: No ]
Secondary Outcome Measure  Biologic measures related to depression in both mothers and infants [ Time Frame: Measured through 14 months fter delivery ] [ Designated as safety issue: No ]
Condition  Depression
Anxiety Disorders
Intervention  Behavioral: Interpersonal Psychotherapy (IPT)
MEDLINE PMIDs
Links Click here for more information at the University of Michigan Clinical Research Website This link exits the ClinicalTrials.gov site
Click here for the University of Michigan Depression Center's website on Interpersonal Therapy This link exits the ClinicalTrials.gov site
Click here for the University of Michigan Depression Center's website on A Woman's Guide to Understanding Depression This link exits the ClinicalTrials.gov site
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  120
Start Date  October 2006
Completion Date December 2008
Eligibility Criteria 

Inclusion Criteria:

  • No more than 28 weeks pregnant at the time of study entry
  • History of depression or anxiety
  • Current symptoms of distress
  • Score of 9 or greater on the Edinburgh Postnatal Depression Scale (EPDS)
  • English-speaking

Exclusion Criteria:

  • Plans to move away from the area prior to giving birth
  • Current use of steroids for medical conditions
Gender Female
Ages 21 Years to 45 Years
Accepts Healthy Volunteers No
Contacts ††
Contact: Katherine H. Bullard, MSW, MPH     734-763-4904     krharris@umich.edu    
Contact: Susan E. Hamilton, MS     734-615-6493     sueileen@umich.edu    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00380419
Organization ID R21 MH72673
Secondary IDs †† DSIR 83-ATAS
Study Sponsor  National Institute of Mental Health (NIMH)
Collaborators ††
Investigators 
Principal Investigator:     Sheila M. Marcus, MD     Universitiy of Michigan    
Information Provided By National Institute of Mental Health (NIMH)
Verification Date February 2008
First Received Date  September 22, 2006
Last Updated Date February 12, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers